CALGARY, Alberta--(BUSINESS WIRE)--Fluid Biomed Inc., a clinical stage medical device company developing lifesaving products for patients suffering from vascular disease, closed an oversubscribed $27 ...

To address concerns of late and very late stent thrombosis associated with first generation drug-eluting stent technology, novel approaches are being tested including stents with bioabsorbable ...

ISAR-TEST-3: Sirolimus-Eluting Stents Using a Durable Polymer vs Bioabsorbable Polymer vs No Polymer for the Prevention of Restenosis DEDICATION STENT: DES vs Bare Metal Stent (BMS) in Acute MI ...

The potential for bioabsorbable polymer implants to replace metal in many applications has generated a great deal of buzz in recent years. However, a multiuniversity consortium is taking a ...

SAN FRANCISCO, CA—At 12 months, a polymer-free, amphilimus-eluting stent was noninferior to a biodegradable-polymer DES in all-comers undergoing PCI, according to results of the PARTHENOPE trial.

For about a decade, bioabsorbable stents were hailed as one of the most promising technologies in cardiology. Now, the future prospects of the technology are less than certain after a clinical trial ...

Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting ...